OASI2: a cluster randomised hybrid evaluation of strategies for sustainable implementation of the Obstetric Anal Sphincter Injury Care Bundle in maternity units in Great Britain. by Jurczuk, M et al.
STUDY PROTOCOL Open Access
OASI2: a cluster randomised hybrid
evaluation of strategies for sustainable
implementation of the Obstetric Anal
Sphincter Injury Care Bundle in maternity
units in Great Britain
Magdalena Jurczuk1* , Posy Bidwell1, Dorian Martinez1, Louise Silverton2, Jan Van der Meulen3,
Daniel Wolstenholme1, Ranee Thakar4†, Ipek Gurol-Urganci1,3† and Nick Sevdalis5†
Abstract
Background: The Obstetric Anal Sphincter Injury (OASI) Care Bundle comprises four primary and secondary
prevention practices that target the rising rates of severe perineal tearing during childbirth, which can have severe
debilitating consequences for women. The OASI Care Bundle was implemented in 16 maternity units in Britain in
the OASI1 project (2017-2018), which demonstrated the care bundle’s effectiveness in reducing OASI rates. In OASI2,
the care bundle will be scaled up to 20 additional National Health Service (NHS) maternity units in a hybrid
effectiveness-implementation study that will examine the effectiveness of strategies used to introduce, implement
and sustain the care bundle.
Methods: OASI2 is a two-arm cluster-randomised control trial (C-RCT) of maternity units in England, Scotland and
Wales, with an additional non-randomised study arm. C-RCT arm 1 (peer support, n = 10 units) will be supported by
‘buddy’ units to implement the OASI Care Bundle. C-RCT arm 2 (lean implementation, n = 10 units) will implement
without external support. The additional study arm (sustainability, n = 10 units) will include some original OASI1
units to evaluate the care bundle’s sustainability and OASI rates over time, from before OASI1 and through the end
of OASI2. Units in all three study arms will receive an Implementation Toolkit with training resources and
implementation support. The C-RCT arms will be compared in terms of OASI rate reduction (primary effectiveness
outcome) and clinicians’ adoption of the care bundle (primary implementation outcome). Clinical data will be
collated from maternity information systems; implementation data will be collected through validated surveys with
women and clinicians, supplemented by qualitative methods. Descriptive statistics and regression modelling will be
used for analysis. Emergent themes from the qualitative data will be assessed using framework analysis.
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Discussion: OASI2 will study the impact of various implementation strategies used to introduce and sustain the
OASI Care Bundle, and how these strategies affect the bundle’s clinical effectiveness. The study will generate
insights into how to effectively scale-up and sustain uptake and coverage of similar interventions in maternity units.
A locally adaptable ‘implementation blueprint’ will be produced to inform development of future guidelines to
prevent perineal trauma.
Trial registration: ISRCTN26523605
Keywords: OASI Care Bundle, Obstetric anal sphincter injury, Severe perineal tear, Scale-up, Quality improvement,
Implementation
Contributions to the literature
 This randomised hybrid implementation-effectiveness trial
aims to determine whether a previously evaluated OASI-
reducing care bundle can be implemented with moderate
or limited implementation support and still achieve signifi-
cant clinical effect.
 Simultaneously, this study will continue to work with
maternity units that implemented the care bundle in a
previous study to identify strategies that successfully support
long-term sustainability.
 This study applies several implementation science
frameworks and measures and will allow determination of
expected mechanisms of implementation. The study will
contribute detailed findings regarding what implementation
strategies worked or did not work in maternity settings and,
importantly, why.
Background
Care bundles have become a popular approach to im-
proving quality of care in the last decade. The Institute
for Healthcare Improvement (IHI) first defined care
bundles in 2001 as ‘a small set of evidence-based prac-
tices that, when implemented together, will result in
significantly better outcomes than when implemented
individually’ [1]. The OASI Care Bundle (OASI-CB) was
developed in response to a tripling in rates of reported
obstetric anal sphincter injury (OASI) in England over a
10-year period [2]. OASI is the collective term for a
third- or fourth-degree perineal tears, a severe complica-
tion of vaginal childbirth that may have long-term con-
sequences including chronic pain, sexual dysfunction,
and urinary and/or anal incontinence [3, 4]. Approxi-
mately one in 13 primiparous women with assisted
vaginal births and one in 20 primiparous women with
unassisted (spontaneous) vaginal births in Great Britain
(GB) are reported to experience an OASI [5]. Over half
of the women who sustain an OASI have continued
morbidities and close to half report an impact on their
future birth choices [6]. Furthermore, OASI has signifi-
cant resource implications for healthcare providers due
to ongoing follow-up and litigation [7].
A multidisciplinary working group of experts from the
Royal College of Midwives (RCM), Royal College of
Obstetricians and Obstetricians (RCOG) and the
London School of Hygiene and Tropical Medicine
(LSHTM) developed the OASI-CB—a set of four routine
practices in maternity care that support the prevention
and early detection of severe perineal tearing (see Fig. 1).
The OASI-CB was implemented and evaluated in a
multicentre quality improvement (QI) project (OASI1)
with a stepped-wedge design from 2016 to 2018 across
16 NHS maternity units in England, Scotland and Wales
[8]. The OASI1 study’s analysis included 55,060 single-
ton live vaginal births and demonstrated the bundle’s
clinical effectiveness: there was a reduction of 20% in the
case-mix-adjusted risk of severe perineal injury after the
introduction of the OASI Care Bundle (p = 0.03), with
no effect on caesarean birth or episiotomy rates [9].
Additionally, a process evaluation within OASI1 found
that the OASI-CB was acceptable, appropriate and feas-
ible for clinicians and women [10, 11].
A variety of other care bundles have been introduced
within maternity care, including ones targeting perinatal
depression [12], stillbirth [13], surgical site infection
after caesarean birth [14] and postpartum haemorrhage
[15]. Despite the rising interest in and use of care
bundles, few studies have examined the mechanisms for
successful and sustainable implementation at scale. A re-
view published in 2019 confirms that the few studies
that report on care bundle implementation processes
lack the detail and standardisation necessary to enable
replication of findings to support the adoption of other
care bundles [16].
Implementation of the OASI-CB in OASI1 relied on
continuous, centralised support from an externally
funded Project Team, an approach that is not always
feasible for scale-up, especially at national scale. This
study—OASI2—will compare how different levels of im-
plementation support impact on maternity units’ uptake
and utilisation of the care bundle to better understand
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how to accomplish sustainable, large-scale implementa-
tion of the OASI-CB in maternity units across GB. Spe-
cifically, OASI2 is a hybrid effectiveness-implementation
trial that focuses on how peer-supported facilitation of
care bundle implementation compares with unsupported
facilitation. The two primary objectives of OASI2 are:
1. To investigate mechanisms and strategies that
support the ongoing sustainability of the OASI-CB
implementation in a sample of the OASI1 study
units
2. To compare effectiveness and implementation
outcomes of two scale-up methods (peer support
and lean implementation) in units implementing
the OASI-CB for the first time.
A secondary objective is to understand women’s per-
spectives regarding the four elements of the care bundle
and their impact on women’s birth experiences.
Methods/design
Conceptual frameworks
The study design is underpinned by one determinant
framework (defines determinants that act as barriers or
enablers to implementation), and one evaluation frame-
work (guides evaluation of implementation) [17]. Appli-
cation of the determinant framework, Promoting Action
on Research Implementation in Health Services (PARI
HS) [18], is described in the Intervention section, and
application of the Implementation Outcomes evaluation
framework [19] is described in the Evaluation section.
Design overview
OASI2 is a two-arm cluster randomised control trial (C-
RCT) with an additional, parallel study arm of purpos-
ively invited units. The additional study arm is referred
to as the ‘sustainability’ arm as it constitutes units that
participated in the original OASI1 study and their efforts
are now focused on sustaining the care bundle over
time. The units in the sustainability arm will continue to
be centrally supported by the Project Team under the
‘expert outreach’ facilitation model.
In all three arms, each unit’s senior leadership will
designate one obstetrician and one midwife to take on
the role of OASI QI Lead. The role of the OASI QI
Leads is to carry out and adapt the recommended imple-
mentation strategies for the local context. The Project
Team will provide all unit leads with an Implementation
Toolkit. The toolkit includes:
 A clinical manual for midwives and obstetricians
that describes how to apply the four components of
the OASI-CB
 Access to an eLearning programme that includes a
clinical module to support skills training
 An implementation guidebook that serves as a
practical blueprint for care bundle roll-out by outlin-
ing how and when to facilitate six key implementa-
tion strategies
 Promotional materials such as posters and other
visual reminders of the OASI-CB
These resources were selected and developed based on
experiences and lessons learned from the OASI1 study.
Fig. 1 Summary of the OASI-CB’s four components
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The units that make up the C-RCT will be randomised
to one of two arms and will implement the OASI-CB
under different facilitation models:
1. Units randomised to C-RCT arm 1 will implement
the OASI-CB with ‘peer support’ from a nearby
maternity unit of the study’s sustainability arm.
2. Units randomised to C-RCT arm 2 will implement
the OASI-CB without peer support. The resources
provided to this group of units are limited to the
contents of the Implementation Toolkit. This
facilitation model is referred to as ‘lean’
implementation.
Figure 2 summarises the study arms.
Study participants
Thirty NHS maternity units across GB will make up the
three study arms (the sustainability arm, and the two C-
RCT arms, peer support and lean implementation) with
ten units in each (see power calculations in the evalu-
ation section).
Inclusion criteria for units in the sustainability arm
are:
 Participation in the OASI1 study
 Attendance and active participation at a co-design
event after OASI1
 A letter of commitment indicating willingness to
sustain the OASI-CB at the organisational level,
continue extracting requested administrative data,
and facilitate protected time for unit leads to
support OASI-CB implementation in neighbouring
units
 Written confirmation of interest in response to a
letter from the Project Team providing additional
details about responsibilities of study participants.
Selection of the units for the C-RCT arms began with
a call for expressions of interest from the clinical direc-
tors and heads of midwifery of all NHS maternity units
across England, Scotland and Wales. Seventy units from
fifty-six NHS Trusts (England) or Boards (Scotland and
Wales) expressed interest to participate. Units from the
same trust/board as a sustainability unit and units that
participated in the pilot study prior to OASI1 were
excluded.
The remaining sixty-four units were divided into six
groups based on their geographical proximity to at least
one sustainability arm unit. Senior staff from sustainabil-
ity arm units were contacted to longlist three units from
their regional groupings that they are able to work with.
Fig. 2 Overview of OASI2 study design
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From each group of three units, the Project Team short-
listed two units that are most similar to each other in
terms of unit type (obstetric unit (OU), alongside
midwifery unit (AMU) or freestanding midwifery unit
(FMU)) and average number of births per year. Blocking
of the candidate units based on the extraneous factor of
sustainability unit preference circumvents the potential
of pairing up two units that are unable to work together,
which would compromise the peer support model evalu-
ated in the trial.
Once the research and development (R&D) depart-
ments from all 20 units have confirmed participation
and completed local set-up processes, within each of the
ten “pairs” of units, units will be randomised into either
peer support or lean implementation arms using a
random number generator by an independent academic
researcher (not associated with institutions linked to the
Project Team). Allocation will be concealed from all
participating units until the launch of the study to pre-
vent premature contact between paired sustainability
arm units and peer support units. The selection and ran-
domisation process is summarised in Fig. 3.
Within each participating maternity unit, there are
three groups of participants: the two OASI QI Leads fa-
cilitating implementation in each unit, the unit clinicians
(midwives and obstetricians), and women who are eli-
gible to receive the care bundle.
Interventions
Implementation mapping and application of the PARIHS
framework
Implementation mapping is a practical tool for planning
the implementation of evidence-based interventions
[20]. Implementation mapping was used to draw on the
lessons learned from OASI1 and apply conceptual
frameworks to define determinants of implementation
Fig. 3 CONSORT flow diagram for selection of C-RCT units
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success and conceptualise implementation outcomes
(see Table 1).
The OASI2 logic model developed as a result of imple-
mentation mapping is shown in Fig. 4.
The logic model takes into account the determinants
of implementation success as defined by the PARIHS
framework, which defines four core ‘determinants’ of im-
plementation success: innovation, context, recipients,
and facilitation [18]. ‘Facilitation’ refers to the OASI QI
Leads leading implementation and acting as facilitators.
‘Recipients’ are the clinicians ‘receiving’ the implementa-
tion and adopting the care bundle into their routine
practice. Facilitation and recipients are therefore internal
determinants of implementation success. Conversely,
‘innovation’ and ‘context’ are external determinants that
may impact the OASI QI Leads and clinicians.
Innovation refers to the acceptability and evidence base
supporting the four components and the OASI-CB as
a whole; depending on the strength of this evidence, this
can have a positive or negative impact on OASI QI
Leads, clinicians, and ultimately, the implementation.
The favourability of the context will further impact im-
plementation. At the national level, this depends on the
opinion of professional clinical leadership and support of
women’s advocacy groups; a favourable local context
includes existing capacity for quality improvement and
senior buy-in early in the implementation period.
Context also takes into account the approval and sup-
port of the care bundle’s target population; women who
are eligible to receive the care bundle and women who
have received it.
The PARIHS framework considers facilitation to be
the “active ingredient” of implementation, acknowledg-
ing that facilitator(s) of change in clinical practice may
be internal or external and focus on enabling others to
make changes [21]. Each of the three study arms are de-
fined by a set of implementation strategies that are influ-
enced by the facilitators involved in the implementation:
 The lean units will rely on their local OASI QI
Leads;
 The peer support units have their local leads + the
support of experienced buddy leads from nearby
units; and
 Sustainability units have their local leads +
centralised support from the Project Team.
Implementation strategies for each study arm were
selected from the compilation of strategies defined by
the Expert Recommendations for Implementation
Change (ERIC) project [22] based on scalability and en-
ablers identified in the OASI1 project. Table 2 details
how each set of discrete implementation strategies will
be operationalised across the three study arms. These
sets of strategies are summarised in the sections below,
for each study arm.
Sustainability arm implementation strategies
In this arm, strategies focus on solidifying the OASI-CB’s
presence by involving and sustaining buy-in from executive
boards in order to incorporate it into local guidelines and
training packages. The aim is to address organisational
barriers and enablers that were identified during OASI1 to
assure the care bundle’s long-term sustainability.
OASI QI Leads in this arm have a dual role: in
addition to local facilitation to ensure sustainability
within their own units, they act as ‘buddy’ facilitators to
nearby units in the peer support study arm (C-RCT arm
1). As buddy facilitators, they are expected to contact
leads from their buddy units at least once per month
and draw on their own experiences to support and ad-
vise on effective operationalisation of implementation
strategies. They will receive the OASI-CB Implementa-
tion Toolkit and continue to receive centralised support
from the Project Team as in OASI1. Centralised support
from the Project Team is delivered to this study arm
through four key strategies:
Table 1 Implementation mapping applied in OASI2
Implementation mapping steps Application in OASI2
1. Conduct a needs and assets assessment and identify adopters
and implementers
• Review of implementation process and lessons learned in OASI1
• Distinguish between roles of senior staff, implementation facilitators and
clinicians
2. Identify adoption and implementation outcomes, performance
objectives, and determinants; create matrices of change
• Establish roles, objectives and outcomes for senior staff, implementation
facilitators, clinicians, and women receiving the care bundle
3. Choose theoretical methods; select or create implementation
strategies
• Selection of the PARIHS framework, implementation outcomes framework
• Theory of Change (see Additional file 1) and Logic model development (Fig. 4)
4. Produce implementation protocols and materials • Tailoring of ERIC strategies across study arms (see Table 2)
• Co-design of the Implementation Toolkit with reference to clinicians’ and
women’s experiences in OASI1, incorporating results from Shared Learning Day
and PPI collaboration
5. Evaluate implementation outcomes • Plan evaluation of clinical outcomes
• Plan evaluation of implementation outcomes
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Fig. 4 OASI2 logic model developed using implementation mapping
Table 2 Implementation strategies operationalised across three study arms
Study
timeline





Set-up Heads of midwifery/clinical directors select one
obstetrician and one midwife to take on the OASI QI
Lead role (informed by a role description)
Identify and prepare champions; facilitation; clinical
supervision
X X X
OASI QI Leads get 1 day/month of protected time to
dedicate to OASI-CB sustainability in own unit and to
support buddy unit
Fund & contract for the clinical innovation X
Launch OASI QI Leads prepared for external facilitator (‘buddy’)
role during virtual skills development days organised
by clinical and implementation experts (Project Team)
Recruit, designate and train for leadership X
OASI QI Leads receive the Implementation Toolkit Develop an implementation blueprint; use
educational materials
X X X
OASI QI Leads paired up with and introduced to their
‘buddies’




OASI QI Leads engage with their ‘buddies’ on a
monthly basis (minimum) to seek implementation
guidance
Provide local technical assistance; shadow other
experts
X
OASI QI Leads to receive centralised support from
clinical and implementation experts (Project Team) via
monthly advisory meetings
Centralise technical assistance; use an
implementation advisor; provide ongoing
consultation; promote network weaving; organize
clinician implementation team meetings
X
Monthly contact between Project Team and heads of
midwifery/ clinical directors to encourage senior buy-
in from key members of staff within unit i.e. Labour
ward lead, Band 7 labour ward co-ordinators, Patient
Safety Leads, QI team etc. and to introduce the OASI-
CB into local guidelines and mandatory training / in-
duction packages for new staff (obstetricians and
midwives)
Involve executive boards; mandate change/ create
or change credentialing and/or licensure standards
X
OASI obstetric anal sphincter injury, QI quality improvement, OASI-CB OASI Care Bundle, ERIC Expert Recommendations for Implementing Change
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1. A live, virtual skills development session with
clinical and implementation experts
2. A dedicated support day from the Project Team’s
clinical leads approximately 2 months after the
virtual skills development session to provide
additional skills development support
3. One day per month of protected time during the
implementation period to be dedicated to OASI QI
Lead responsibilities
4. Monthly catch-up calls with OASI QI Leads to
follow-up on progress of sustainability efforts
Peer support (C-RCT arm 1) implementation strategies
The ten units randomised to this study arm are paired
with units from the sustainability arm. The OASI QI
Leads in this arm will receive the Implementation Tool-
kit and benefit further from continuous external support
from the sustainability arm, their buddy facilitators.
OASI QI Leads in the peer support arm will maintain
monthly contact with their buddy facilitators. Continu-
ous peer support is the defining feature of this scale-up
method that distinguishes it from lean implementation
(see below).
Lean implementation (C-RT arm 2) implementation
strategies
Units in this arm will be testing the most ‘hands-off’
scale-up method for care bundle implementation. As is
standard across the three arms, the two OASI QI Leads
will receive the Implementation Toolkit which is
designed to guide and support implementation efforts.
As most improvement interventions within the NHS do
not provide external facilitation or implementation sup-
port, this study arm is most similar to current practice
and therefore most akin to a control group. Provision of
the Implementation Toolkit replicates what sometimes
(though not systematically or as specifically) is offered as
implementation support [23] or QI support [24] within
the NHS.
Evaluation of OASI2
Evaluation framework and study outcomes
Clinical and implementation effectiveness data will be
collected across all three study arms using mixed
methods. All data sources and study outcomes are
outlined in Fig. 5, which adopts an ‘iceberg model’ [25]
to illustrate the three different levels of perspectives
evaluated: the OASI-CB, implementation strategies and
facilitation model. Clinical effectiveness outcomes are fo-
cused on the OASI-CB, the visible ‘tip of the iceberg,’
while implementation outcomes span all the three levels,
elucidating the role and impact of implementation strat-
egies and the facilitation model (peer supported vs. lean
implementation).
The Proctor et al. implementation outcome taxonomy
[19] guides our evaluation of several implementation
outcomes across the three levels shown in Fig. 5. The
implementation outcomes are either perception-based or
action-based. Acceptability (Is it agreeable, palatable,
satisfactory?), appropriateness (Is it compatible?) and
feasibility (Is there capacity to do this?) are evaluated
based on how an evidence-based intervention (EBI) and/
or its implementation are perceived. Adoption of the
EBI, fidelity (Is the EBI/its implementation carried out as
intended?), the EBI’s coverage of the target population
and sustainability are evaluated based on actions taken
or behaviours changed.
The facilitation model is assessed based on how facili-
tators perceive its acceptability and appropriateness and
feasibility.
Implementation strategies are assessed based on
whether facilitators deliver the strategies as intended,
whether clinicians engage or participate in the strategies
as expected (fidelity to the delivery of and engagement
with the strategies), and how clinicians perceive their ac-
ceptability and appropriateness.
The OASI-CB is assessed in terms of how clinicians
perceive its acceptability, appropriateness and feasibility,
and whether clinicians adopt the care bundle with fidel-
ity (as intended) into their routine practice and offer it
Fig. 5 Three-level ‘iceberg model’ with study outcomes and data sources
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at high coverage. The primary implementation outcome
(adoption) and clinical effectiveness outcome (OASI
rate) are both measured at this level.
Study hypotheses
There are two hypotheses, one related to the primary
clinical effectiveness outcome (OASI rates) and one to
the primary implementation outcome (OASI-CB adoption):
1. The OASI rate will decrease in all study arms
following the implementation of OASI-CB. There
will be a significant difference in reduction of OASI
rates between units in the peer support and lean
implementation arms, such that the reduction in
OASI rates will be higher in the peer support arm
as compared with the reduction in OASI rates in
the lean implementation arm.
2. There will be a significant difference in care bundle
adoption between units in the peer support and
lean implementation arms, such that the levels of
adoption will be higher in the peer support arm.
Sample size and power
The sample size calculation aimed to identify the mini-
mum number of clusters (maternity units) required to
provide a study power of at least 0.80 with a statistical sig-
nificance level of 0.05 to detect a 0.5% difference in OASI
rates between the peer support and lean implementation
arms following the implementation of OASI-CB.
The OASI rate is 3.5% according to the National
Maternity and Perinatal Audit (NMPA) [5]. The units in
the peer-support arm are expected to achieve a similar
rate of reduction in OASI rates as the relative reduction
of 20% observed in OASI1, or in absolute terms a reduc-
tion in OASI rates from 3.5% to 2.8%. We assume that
the relative reduction in the lean implementation arm
will be only 5%, or in absolute terms a reduction in
OASI rates from 3.5% to 3.3%.
Using the Shiny CRT Calculator [26] by Hemming
et al. and a trial design that includes baseline measures,
a cross-sectional sampling, an exchangeable correlation
structure, a cluster size of 3600 (average maternity unit
size according to NMPA), allowance for a varying cluster
sizes (coefficient of variation 0.4 according to the
NMPA), and an intraclass correlation of 0.007 (accord-
ing to OASI1), the minimum number of clusters would
detect the assumed difference in OASI after implemen-
tation of the OASI-CB is ten; therefore, the study will
have ten units in each trial arm.
Clinical effectiveness evaluation
Data collection and management
The clinical effectiveness of the OASI-CB is evaluated
through its impact on perineal outcomes in women
across all participating units. As OASI is an acute preg-
nancy outcome, women may receive the four elements
of the bundle as they become eligible, dependent on
whether the attending clinician (midwife or obstetrician)
chooses to, or is trained to use the care bundle. Women
are not randomised to receive the care bundle. All
women who have a vaginal birth (spontaneous or
assisted) are eligible to receive the OASI-CB, unless they
do not consent to one of the elements of the care bundle
or are in a birthing position that makes it unfeasible to
implement all elements of the care bundle (e.g. water
birth).
Individual woman-level data will be extracted from
local electronic Maternity Information Systems (MIS)
for all participating units in England, Scotland and
Wales. The MIS data extract will include demographic
and clinical information related to primary and second-
ary clinical outcomes, as well as a small set of variables
required for cohort derivation and risk adjustment. Data
will not be patient identifiable. The full data specification
can be found in Additional file 2.
Baseline data extracts will be requested from the 20
randomised units covering 1 year prior to the start of
the OASI2 implementation period. For the ten units in
the sustainability arm, baseline data extracts will cover
the time period between end of the OASI1 study and
start of OASI2. All subsequent data extracts during the
implementation period will be requested quarterly to en-
able the Project Team to monitor the quality of the data
extracts and to resolve any data-related queries early on.
During the implementation period, clinicians will be
asked to record their use of (or compliance with) the
OASI-CB for every vaginal birth they attend. At mini-
mum, this will be a single yes/no question: ‘were all four
components of the OASI-CB applied to this birth?’
Where possible, a field will be added to the local MIS to
facilitate collection of these data.
Data from each unit will be cleaned and re-coded to
ensure consistent definitions for all variables. Data qual-
ity will be assessed by checking data completeness,
plausible distributions and internal consistency. Multiple
imputation methods (e.g. statistical coefficients obtained
from ten imputed data sets pooled using Rubin’s rules
[26]) will be used to deal with missing data, if possible,
following an assessment of the extent and patterns of
missing data. Plausible distribution checks include
assessing whether the distributions calculated from non-
missing data is within a clinically possible and acceptable
range (e.g. OASI rates less than 15%). Internal
consistency checks include assessing agreement of data
that might be present in more than one data field (i.e.
repair of a tear would only be recorded in women who
had an OASI). Any implausible distributions or high
levels of internal inconsistency would suggest data
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extraction errors or systematic errors in coding,
which would need to be discussed with the unit’s
MIS team, and a new revised extract will be re-
quested if required.
Data analysis
Routine data extracted from the MIS will be first
analysed descriptively, with OASI rates, caesarean birth
rates, episiotomy rates and OASI-CB use calculated for
all eligible women pre and post implementation and by
study arms. Because units in the sustainability arm have
already implemented the OASI-CB as part of OASI1,
effectiveness outcomes in these units will be analysed
differently than in the two C-RCT arms.
For the C-RCT arms, multilevel logistic regression and
estimation of adjusted odds ratios (aOR) will be used to
assess the impact of the OASI-CB and the relative differ-
ences in the odds of OASI in the two C-RCT arms. The
regression model will include a random effect to account
for clustering at unit level, secular trends and individual
case-mix factors (e.g. maternal age, ethnicity, BMI, par-
ity, mode of birth and birthweight).
For the sustainability arm, OASI rates will be analysed
longitudinally from the baseline period of OASI1 to end
of OASI2, to ascertain the trends and the rate of change
by various implementation strategies. The four specific
time periods will include baseline (pre-OASI1), OASI1
implementation, post-OASI1 with no external support
and OASI2. We will use multilevel logistic regression
with random effects and case-mix adjustment as in the
C-RCT arms, to estimate adjusted odds ratios (aOR) for
each time period and to test the significance of the
relative impact of OASI1 implementation as compared
with OASI2 implementation to assess the effectiveness
of additional “sustainability” strategies.
For all study arms, subgroup analyses of the effect of
the care bundle on OASI rates will be carried out
according to mode of birth (spontaneous or assisted)
and parity. The Wald test will be used to test for signifi-
cance of interaction terms.
The analysis will be done following intention-to-treat
principle, with births analysed according to whether they
took place during the baseline or implementation
periods, irrespective of whether or not all aspects of the
care bundle could be implemented.
Implementation evaluation
Four surveys will be used to collect unit-level data: a
contextual assessment survey, an Implementation
Process Survey for OASI QI Leads, a clinicians’ survey,
and a postnatal survey for women. Qualitative methods
in the form of activity logs and focus group discussions
will also be used. Timing of data collection activities are
outlined in Fig. 6.
Contextual survey
A contextual survey will complement subsequent ana-
lyses and evaluations of OASI-CB implementation at the
unit and study arm levels to determine how maternity
unit context impacts care bundle implementation. The
survey will assess factors identified as significant to im-
plementation OASI1 (i.e. number of staff, number of
students, level of research activity) as well as the impact
of the COVID-19 pandemic. Each unit’s maternity gov-
ernance team will complete this survey, administered
online, at project start.
Fig. 6 OASI2 study timeline
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Implementation process survey with OASI QI Leads
OASI QI Leads will be surveyed at two points during
the study: during the first and last three months of the
implementation period. These surveys focus on the
facilitation model and will measure perceptions of the
expert outreach support received by the sustainability
arm units, the peer support model or the lean imple-
mentation model. These surveys include the previously
developed acceptability of intervention measure (AIM),
intervention appropriateness measure (IAM) and the
feasibility of intervention measure (FIM) [27]. Both
OASI QI Leads for all 30 participating units will be in-
vited to complete the survey.
Clinicians’ survey
Midwives and obstetricians from participating units will
be invited to complete a survey in the first and last three
months of the implementation period that will measure:
 Adoption of the OASI-CB
 Perceptions of the OASI-CB
 Perceptions of the implementation strategies
 Participation in implementation strategies
The AIM, IAM and FIM are used as in the survey with
OASI QI Leads. Adoption is measured using the
Normalization Measurement Development (NoMAD)
Tool [28], developed in line with constructs of the
Normalization Process Theory, which focuses on the
work done at an individual level by adopters of new
practices. All midwives and obstetricians will be invited
to participate by way of a census method.
Women’s postnatal surveys
Women who give birth in participating units will be sur-
veyed about their experiences with the OASI-CB. Survey
questions have been extensively reviewed by patient and
public involvement (PPI) groups for sensitivity. Over a 4-
month period, all women who had a live vaginal birth will
be invited to participate in the survey by way of a census
method. An attending clinician will approach eligible
women at an appropriate time after birth and before dis-
charge from the hospital to explain the survey and provide
a participant information sheet and consent form. Partici-
pants will receive a link to the online survey via e-mail 2
weeks after the birth of their baby and up to three re-
minders thereafter if the survey has not yet been completed.
Assuming a 30% response rate [29, 30], an estimated 8000
surveys will be completed, which is adequate for descriptive
analyses (no comparators for these survey data).
Survey data analysis
All survey data will be aggregated for each assessed im-
plementation outcome. For previously validated scales
(e.g. AIM, IAM, FIM, NoMAD) internal consistency will
be first calculated (Cronbach’s alpha coefficients). Assum-
ing acceptable reliability (Cronbach’s alpha of 0.70 or
higher), item ratings will be aggregated into scale scores.
Multivariate regression analyses with clinicians’ survey
data will explore the relationship between favourable
care bundle perceptions and high care bundle adoption
(outcomes) and implementation strategies used and fa-
cilitation model assigned to the study arm (predictors).
Analyses will also explore the impact of contextual fac-
tors (size and type of unit, prevalence of students, staff
turnover rates).
Results from the OASI QI Leads’ and clinicians’ sur-
veys from the two time points will be compared within
units to assess rating/score variation over time.
Fidelity assessment will be carried out as follows: OASI
QI Leads’ survey data for each outcome will be com-
pared with clinicians’ awareness of, participation in and
perceptions of the discrete implementation strategies
used in unit from the clinicians’ survey. Clinicians’
awareness of strategies in their unit serves as a proxy
indicator of OASI QI Leads’ fidelity to the prescribed
implementation strategies. Clinicians’ participation in
and perceptions of the strategies will be taken as indica-
tors of the clinicians’ fidelity to engagement with the
strategies.
Women’s postnatal survey data will be analysed de-
scriptively by each of the OASI-CB components and will
be compared between units within study arms. No spe-
cific hypotheses will be tested in relation to this dataset.
Implementation activity logs
To gain insight into the units’ implementation processes,
OASI QI Leads will keep a log of their implementation
efforts and share it with the Project Team at two time
points: after the 1-month transition period and after the
12-month implementation period. Twenty logs (one
from each unit) will be received by the Project Team at
the two time points. As a quality and completeness as-
surance measure, a member of the Project Team will
schedule a telephone call with each unit (with both unit
leads, if possible) to follow up on the submitted logs and
to fill in any missing information.
The Project Team will have monthly contact with
OASI QI Leads from the sustainability arm, which will
be guided by the activity logs; leads will therefore be
asked to share activity logs on a monthly basis.
Each planned and reported activity will be matched to
one or more of the 73 discrete implementation strategies
compiled by the ERIC Project, as described in Table 2.
Content analysis will be used to code any obstacles re-
ported by OASI QI Leads. The matched strategies,
coded obstacles and additional information collected in
the logs such as number of participants and amount of
Jurczuk et al. Implementation Science           (2021) 16:55 Page 11 of 14
time spent will be entered in a data file. The information
will be identifiable by unit and study arm. After the sec-
ond round of activity logs are received and entered into
the file, the data will be analysed descriptively to identify
any patterns between implementation strategies and the
facilitation model.
Focus groups with OASI QI Leads
Focus group discussions (FGDs) will be conducted with
OASI QI Leads to further understand the scalability of
the different facilitation models and the operationalisa-
tion of the different implementation strategies. The dis-
cussion will be guided by the study’s underpinning
conceptual frameworks.
Each FGD will have six to eight participants, compris-
ing an even distribution of obstetric and midwifery leads.
The FGDs will be conducted virtually and will take ap-
proximately 60 min. FGDs will be recorded and tran-
scribed verbatim and field notes summarised. All
transcripts will be anonymised and de-identified.
There will be three sets of FGDs specific to each of the
three facilitator roles. Each FGD will only have leads from
the same study arm. Leads will be strategically assigned/
distributed as to not be grouped with their co-lead in a
focus group. The number of FGDs conducted depends on
the repetition of emergent themes (data saturation) [31].
A deductive approach will be taken to the framework
analysis method through the use of PARIHS framework
and Normalisation Process Theory constructs to guide
data collection and its subsequent coding. The frame-
work analysis method is well-suited for comparing and
contrasting data across themes, which is appropriate as
we seek to compare the two facilitation models of peer
implementation and lean implementation [32].
Synthesis of clinical effectiveness and implementation
data
If compliance (clinicians’ use of the OASI-CB) and sur-
vey data are of sufficient completeness and quality, this
unit level data will be added to multivariate regression
models with effectiveness data to identify and estimate
any relationship between OASI rates and levels of OASI-
CB adoption as well as any secondary implementation
outcomes. For the two C-RCT arms, the regression ana-
lysis will assess the impact of care bundle adoption
(based on NoMAD score from clinicians’ survey) on
relative differences of odds of OASI. In the sustainability
arm, the regression analysis will assess the impact of
additional ‘sustainability strategies’ on the adoption of
the care bundle and on odds of OASI.
Women’s and stakeholder involvement
Women’s involvement is central to the development of
this study. Women's insights on both the
implementation and evaluation of OASI2 have been
prioritised and incorporated. As the study progresses,
women’s involvement will continue to guide study activ-
ities, including how to support participating maternity
units to effectively engage with women and to embed
this engagement in local practice.
As part of the study’s governance of OASI2, an
Independent Advisory Group (IAG) provides the OASI2
project team with expert, independent advice and will
provide recommendations on implementation and evalu-
ation. The OASI2 IAG consists of clinicians representing
obstetrics, gynaecology and midwifery; methodological
and clinical leads; implementation and mobilisation sci-
ence experts; women’s representatives; and representa-
tives from two women’s stakeholder organisations,
MASIC (Mothers with Anal Sphincter Injuries in Child-
birth) and the Birth Trauma Association (BTA). The
IAG and project team meet every 6 months, at a
minimum.
Discussion
OASI2 is a pragmatic, theory-driven hybrid
effectiveness-implementation study that will evaluate the
implementation of a care bundle in UK NHS maternity
units by identifying and elucidating the role of specific
stakeholders and other factors that act as determinants
of implementation success in addition to using standar-
dised taxonomy in the reporting and study of implemen-
tation strategies. A pragmatic approach is taken in the
study design as well as the development of implementa-
tion materials and the monitoring and evaluation plan.
The two implementation support methods to be com-
pared were selected as feasible options for national
scale-up. The Implementation Toolkit was developed by
experienced clinicians and aims to assist implementation
by passing on lessons learned in a way that can be both
operationalised and localised. Study findings will be
shared widely through peer-reviewed publications, evi-
dence briefs, and media/social media channels. Beyond
OASI2, through triangulation of data and theory, this
study aspires to create a more thorough understanding
of barriers and enablers to the sustainable, large-scale
implementation of care bundles in maternity care.
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